PLSE
Pulse Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Ample Liquidity
Negative Gross Margin
Significant Net Income Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PLSE
Pulse Biosciences, Inc.
A novel bioelectric medicine company that develops medical devices based on a nano-pulse electro signaing platform for the treatment of tumors
Healthcare Equipment and Supplies
05/19/2014
05/18/2016
NASDAQ Stock Exchange
75
12-31
Common stock
3957 Point Eden Way, Hayward, CA 94545
--
Pulse Biosciences, Inc., incorporated in Nevada on May 19, 2014 under the name Electroblate, Inc., is a medical device company using a new and proprietary platform technology, nano-pulsed electrical signaling, or NPES in the developmental stage of biomedical applications. Electroblate, Inc., was renamed Pulse Biosciences Corporation, effective December 8, 2015.
Earnings Call
Q1/2025
Estimate EPS--
Actual EPS-0.25
Estimate Revenue--
Actual Revenue--
Pulse Biosciences Q1 2025: Navigating Contradictions in Product Progress, Regulatory Pathways, and Financial Outlook
May 19,2025 05:43
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS--
Actual EPS-0.28
Estimate Revenue--
Actual Revenue0
Pulse Biosciences' Q2 2025: Unraveling Contradictions in Partnerships, R&D, and Clinical Strategies
Aug 12,2025 11:39
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
PLSE has released its 2025 Q3 earnings. EPS was reported at -0.2, versus the expected -0.31, beating expectations. The chart below visualizes how PLSE has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PLSE has released its 2025 Q3 earnings report, with revenue of 86.00K, reflecting a YoY change of NaN%, and net profit of -19.39M, showing a YoY change of -52.88%. The Sankey diagram below clearly presents PLSE's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
